Cargando…

Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects

BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) circulates as mature and furin-cleaved forms, which differ in their properties to degrade low-density lipoprotein (LDL) receptors. OBJECTIVES: In this study, we sought to investigate whether PCSK9 subtypes associate with atherosclerot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Yu, Harada-Shiba, Mariko, Hori, Mika, Watanabe, Makoto, Kokubo, Yoshihiro, Noguchi, Teruo, Yasuda, Satoshi, Miyamoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627806/
https://www.ncbi.nlm.nih.gov/pubmed/36341208
http://dx.doi.org/10.1016/j.jacasi.2021.09.003
_version_ 1784823052679249920
author Kataoka, Yu
Harada-Shiba, Mariko
Hori, Mika
Watanabe, Makoto
Kokubo, Yoshihiro
Noguchi, Teruo
Yasuda, Satoshi
Miyamoto, Yoshihiro
author_facet Kataoka, Yu
Harada-Shiba, Mariko
Hori, Mika
Watanabe, Makoto
Kokubo, Yoshihiro
Noguchi, Teruo
Yasuda, Satoshi
Miyamoto, Yoshihiro
author_sort Kataoka, Yu
collection PubMed
description BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) circulates as mature and furin-cleaved forms, which differ in their properties to degrade low-density lipoprotein (LDL) receptors. OBJECTIVES: In this study, we sought to investigate whether PCSK9 subtypes associate with atherosclerotic cardiovascular events. METHODS: We investigated 1,436 statin-naive Japanese subjects without any cardiovascular disease in the Suita Study, an epidemiologic Japanese cohort study. Total, mature, and furin-cleaved PCSK9 levels were measured by means of enzyme-linked immunosorbent assay. The occurrence of coronary and stroke events were compared in subjects stratified by PCSK9 level tertile. RESULTS: Total, mature, and furin-cleaved PCSK9 levels were associated with non–high-density lipoprotein cholesterol (all P < 0.001) and systolic blood pressure (P = 0.001, P = 0.004, and P < 0.001, respectively). Furthermore, only furin-cleaved PCSK9 level was correlated to high-sensitivity C-reactive protein (hs-CRP) (P < 0.001). During the 13.6-year observational period, furin-cleaved PCSK9 level predicted a greater likelihood of experiencing coronary events (tertile 2: hazard ratio [HR]: 2.84 [95% confidence interval [CI]: 1.21-6.65; P = 0.01]; tertile 3: HR: 2.81 [95% CI: 1.17-6.74; P = 0.02]), but not stroke (tertile 2: HR: 1.31 [95% CI: 0.72-2.40; P = 0.36]; tertile 3: HR: 1.27 [95% CI: 0.68-2.38; P = 0.44]). Total and mature PCSK9 levels were not associated with coronary events (total PCSK9: tertile 2: HR: 1.35 [95% CI: 0.68-2.68; P = 0.39]; tertile 3: HR: 1.13 [95% CI: 0.54-2.34; P = 0.73]; mature PCSK9: tertile 2: HR: 1.02 [95% CI: 0.52-2.02; P = 0.93]; tertile 3: HR: 0.96 [95% CI: 0.47-1.95; P = 0.92]) and stroke events (total PCSK9: tertile 2: HR: 0.90 [95% CI: 0.50-1.61; P = 0.72]; tertile 3: HR: 0.99 [95% CI:0.54-1.80; P = 0.97]; mature PCSK9: tertile 2: HR: 0.86 [95% CI: 0.47-1.57; P = 0.63]; tertile 3: HR: 1.11 [95% CI: 0.61-1.99; P = 0.72]), respectively. CONCLUSIONS: Furin-cleaved but not total and mature PCSK9 was associated with both LDL cholesterol and hs-CRP and predicted future coronary events in the primary prevention settings. Our findings provide pathophysiological insights into the properties of PCSK9 subtypes in association with coronary events.
format Online
Article
Text
id pubmed-9627806
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96278062022-11-04 Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects Kataoka, Yu Harada-Shiba, Mariko Hori, Mika Watanabe, Makoto Kokubo, Yoshihiro Noguchi, Teruo Yasuda, Satoshi Miyamoto, Yoshihiro JACC Asia Original Research BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) circulates as mature and furin-cleaved forms, which differ in their properties to degrade low-density lipoprotein (LDL) receptors. OBJECTIVES: In this study, we sought to investigate whether PCSK9 subtypes associate with atherosclerotic cardiovascular events. METHODS: We investigated 1,436 statin-naive Japanese subjects without any cardiovascular disease in the Suita Study, an epidemiologic Japanese cohort study. Total, mature, and furin-cleaved PCSK9 levels were measured by means of enzyme-linked immunosorbent assay. The occurrence of coronary and stroke events were compared in subjects stratified by PCSK9 level tertile. RESULTS: Total, mature, and furin-cleaved PCSK9 levels were associated with non–high-density lipoprotein cholesterol (all P < 0.001) and systolic blood pressure (P = 0.001, P = 0.004, and P < 0.001, respectively). Furthermore, only furin-cleaved PCSK9 level was correlated to high-sensitivity C-reactive protein (hs-CRP) (P < 0.001). During the 13.6-year observational period, furin-cleaved PCSK9 level predicted a greater likelihood of experiencing coronary events (tertile 2: hazard ratio [HR]: 2.84 [95% confidence interval [CI]: 1.21-6.65; P = 0.01]; tertile 3: HR: 2.81 [95% CI: 1.17-6.74; P = 0.02]), but not stroke (tertile 2: HR: 1.31 [95% CI: 0.72-2.40; P = 0.36]; tertile 3: HR: 1.27 [95% CI: 0.68-2.38; P = 0.44]). Total and mature PCSK9 levels were not associated with coronary events (total PCSK9: tertile 2: HR: 1.35 [95% CI: 0.68-2.68; P = 0.39]; tertile 3: HR: 1.13 [95% CI: 0.54-2.34; P = 0.73]; mature PCSK9: tertile 2: HR: 1.02 [95% CI: 0.52-2.02; P = 0.93]; tertile 3: HR: 0.96 [95% CI: 0.47-1.95; P = 0.92]) and stroke events (total PCSK9: tertile 2: HR: 0.90 [95% CI: 0.50-1.61; P = 0.72]; tertile 3: HR: 0.99 [95% CI:0.54-1.80; P = 0.97]; mature PCSK9: tertile 2: HR: 0.86 [95% CI: 0.47-1.57; P = 0.63]; tertile 3: HR: 1.11 [95% CI: 0.61-1.99; P = 0.72]), respectively. CONCLUSIONS: Furin-cleaved but not total and mature PCSK9 was associated with both LDL cholesterol and hs-CRP and predicted future coronary events in the primary prevention settings. Our findings provide pathophysiological insights into the properties of PCSK9 subtypes in association with coronary events. Elsevier 2021-11-23 /pmc/articles/PMC9627806/ /pubmed/36341208 http://dx.doi.org/10.1016/j.jacasi.2021.09.003 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Kataoka, Yu
Harada-Shiba, Mariko
Hori, Mika
Watanabe, Makoto
Kokubo, Yoshihiro
Noguchi, Teruo
Yasuda, Satoshi
Miyamoto, Yoshihiro
Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
title Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
title_full Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
title_fullStr Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
title_full_unstemmed Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
title_short Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
title_sort circulating furin-cleaved proprotein convertase subtilisin/kexin type 9 concentration predicts future coronary events in japanese subjects
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627806/
https://www.ncbi.nlm.nih.gov/pubmed/36341208
http://dx.doi.org/10.1016/j.jacasi.2021.09.003
work_keys_str_mv AT kataokayu circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects
AT haradashibamariko circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects
AT horimika circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects
AT watanabemakoto circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects
AT kokuboyoshihiro circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects
AT noguchiteruo circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects
AT yasudasatoshi circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects
AT miyamotoyoshihiro circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects